NUTX

Over the past six months, Nutex Health Inc. (NUTX) stock has increased by 109.26%. As of September 16, 2026, the share price was $217.32, a 141.53% increase from September 17, 2025. Recent performance includes a 7.32% return over 30 days and a 21.31% return over 90 days, though it saw dips of 3.33% over the past day and 5.81% over the past week as of September 24, 2026. On September 23, 2026, shares fell 3.3% to $201.86. A key event was the approval on September 22, 2026, for dual-listing its common stock on Nasdaq Texas, aiming to boost liquidity and investor access while maintaining its Nasdaq Global Market listing. Despite this, the stock is considered significantly overvalued, with its price of $201.86 being 143.7% above its GF Value™ of $82.83 as of September 23, 2026. Earnings reports have also impacted the stock; after reporting earnings on August 6, 2026, shares gained 6.7% the next day and drifted 16.8% higher over the subsequent 24 days. The company also reported strong first-quarter 2026 financial results on April 30, 2026, with total revenue up 2.2% and net income attributable to Nutex Health up 120.6% year-over-year.